Soleno Therapeutics, Inc. (NASDAQ:SLNO) is one of the 10 Unstoppable Stocks to Buy According to Hedge Funds. On June 23, TD ...

TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” ...

Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the ...

A high-level overview of Soleno Therapeutics, Inc. (SLNO) stock. View (SLNO) real-time stock price, chart, news, analysis, analyst reviews and more.

Conference is the first-ever international meeting jointly hosted by the Prader-Willi Syndrome Association | USA, the ...

Opportunity, LLC Vivo, a 10% owner of $SLNO, sold 1,100,000 shares of the company on 03-27-2025 for an estimated $74,580,000. We received data on the trade from a ...

Soleno Therapeutics (SLNO) is scheduled to report earnings on March 5, 2025. The last reported earnings were for reported on November 6, 2024 for Q3 ...

Soleno Therapeutics, Inc. (SLNO) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends ...